Patent details

EP4346818 Title: SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE

Basic Information

Publication number:
EP4346818
PCT Application Number:
US2022032253
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227410503
PCT Publication Number:
WO2022256708
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE
French Title of Invention:
FORMES DE DOSAGE SOLIDES ET REGIMENS DE DOSAGE COMPRENANT LE [[3-(3,4-DIFLUORO-2-MÉTHOXY-PHÉNYL)-4,5-DIMÉTHYL-5-(TRIFLUOROMÉTHYL) TÉTRAHYDROFURANNE-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE
German Title of Invention:
FESTE DARREICHUNGSFORMEN UND DOSIERUNGSSCHEMATA ENTHALTEND [[3-(3,4-DIFLUOR-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUORMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDIN-2-CARBOXAMID
SPC Number:

Dates

Filing date:
03/06/2022
Grant date:
03/12/2025
EP Publication Date:
10/04/2024
PCT Publication Date:
08/12/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/12/2025
EP B1 Publication Date:
03/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/06/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/11/2025
 
 

Name:
Vertex Pharmaceuticals Incorporated
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/01/2026
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BENITO GALLO, Paloma
Address:
United States (US)

2

Name:
STAROPOLI, John F.
Address:
United States (US)

3

Name:
CIRINCIONE, Brenda
Address:
United States (US)

4

Name:
CHU, Cathy
Address:
United States (US)

5

Name:
DINEHART, Kirk Raymond
Address:
United States (US)

6

Name:
PETERSON, Mark C.
Address:
United States (US)

7

Name:
CORRELL, Darin J.
Address:
United States (US)

8

Name:
METZLER, Catherine P.
Address:
United States (US)

9

Name:
MILLER, Jonathan M.
Address:
United States (US)

10

Name:
MCCARTY, Katie L.
Address:
United States (US)

11

Name:
DELFF, Philip Kaj Harder
Address:
United States (US)

12

Name:
JIANG, Licong
Address:
United States (US)

13

Name:
HAY, Tanya Louise
Address:
United States (US)

14

Name:
KARKARE, Radhika
Address:
United States (US)

15

Name:
JONES, James B.
Address:
United States (US)

16

Name:
ROOPWANI, Rahul
Address:
United States (US)

Priority

1

Priority Number:
202163196937 P
Priority Date:
04/06/2021
Priority Country:
United States (US)

2

Priority Number:
202163196933 P
Priority Date:
04/06/2021
Priority Country:
United States (US)

3

Priority Number:
202163285201 P
Priority Date:
02/12/2021
Priority Country:
United States (US)

4

Priority Number:
202163285197 P
Priority Date:
02/12/2021
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/443; A61P 23/00; A61P 25/02; A61P 29/00; A61K 9/20;

Publication

European Patent Bulletin

1

Issue number:
202549
Publication date:
03/12/2025
Description:
Grant (B1)

2

Issue number:
202602
Publication date:
07/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
16/01/2026 Outgoing Correspondence 1
12/01/2026 Power Of Attorney 1